MANE is trading 4.3% higher at $133.98 in pre-market action, extending a strong multi-day rally for Veradermics, Incorporated.
- The stock continues to push into new 52-week territory, driven by investor enthusiasm for recent clinical trial data.
- Gains are supported by a broader breakout in the biotech sector, with the move appearing to be momentum-driven as no new company-specific headlines have been released today.